Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 12
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2DP25F2790 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-01-28 | 2025-02-04 | 325412 | 8511147948!ADENOVIRUS TYPE 4 A |
| SPE2DP25F1163 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-11-20 | 2024-12-03 | 325412 | 8511030464!ADENOVIRUS TYPE 4 A |
| SPE2DP25F0861 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-11-14 | 2024-11-19 | 325412 | 8511009837!ADENOVIRUS TYPE 4 A |
| SPE2DP25F0860 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-11-14 | 2024-11-19 | 325412 | 8511009836!ADENOVIRUS TYPE 4 A |
| SPE2DP24F8002 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-09-18 | 2024-09-24 | 325412 | 8510902356!ADENOVIRUS TYPE 4 A |
| SPE2DP24F8001 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-09-18 | 2024-09-24 | 325412 | 8510902355!ADENOVIRUS TYPE 4 A |
| SPE2DP24F7174 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-08-22 | 2024-08-27 | 325412 | 8510839954!ADENOVIRUS TYPE 4 A |
| SPE2DP24F7173 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-08-22 | 2024-08-27 | 325412 | 8510839950!ADENOVIRUS TYPE 4 A |
| SPE2DP24F6270 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-07-19 | 2024-07-30 | 325412 | 8510767084!ADENOVIRUS TYPE 4 A |
| SPE2DP24F6268 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-07-19 | 2024-07-30 | 325412 | 8510767029!ADENOVIRUS TYPE 4 A |
| SPE2DP24F5490 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-06-13 | 2024-06-25 | 325412 | 8510688513!ADENOVIRUS TYPE 4 A |
| SPE2DP24F5489 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-06-13 | 2024-06-25 | 325412 | 8510688512!ADENOVIRUS TYPE 4 A |
| SPE2DP24F4774 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-05-15 | 2024-05-21 | 325412 | 8510634435!ADENOVIRUS TYPE 4 A |
| SPE2DP24F4771 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-05-15 | 2024-05-21 | 325412 | 8510634349!ADENOVIRUS TYPE 4 A |
| SPE2DP24F3916 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-04-09 | 2024-04-30 | 325412 | 8510559078!ADENOVIRUS TYPE 4 A |
| SPE2DP24F3913 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-04-09 | 2024-04-30 | 325412 | 8510559019!ADENOVIRUS TYPE 4 A |
| SPE2DP24F3361 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-03-19 | 2024-03-26 | 325412 | 8510516989!ADENOVIRUS TYPE 4 A |
| SPE2DP24F2013 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-01-25 | 2024-01-30 | 325412 | 8510401962!ADENOVIRUS TYPE 4 A |
| SPE2DP24F2005 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $317.61K | 2024-01-25 | 2024-01-30 | 325412 | 8510401887!ADENOVIRUS TYPE 4 A |
| SPE2DP24F1260 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-12-14 | 2023-12-19 | 325412 | 8510330652!ADENOVIRUS TYPE 4 A |
| SPE2DP23F6111 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-09-12 | 2023-09-19 | 325412 | 8510134512!ADENOVIRUS TYPE 4 A |
| SPE2DP23F6110 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-09-12 | 2023-09-19 | 325412 | 8510134414!ADENOVIRUS TYPE 4 A |
| SPE2DP23F5672 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-08-22 | 2023-08-29 | 325412 | 8510093091!ADENOVIRUS TYPE 4 A |
| SPE2DP23F5670 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-08-22 | 2023-08-29 | 325412 | 8510093037!ADENOVIRUS TYPE 4 A |
| SPE2DP23F5669 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-08-22 | 2023-08-29 | 325412 | 8510093032!ADENOVIRUS TYPE 4 A |